| Drug Name |
Travoprost |
| Drug ID |
BADD_D02265 |
| Description |
Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure [FDA Label]. It is a synthetic prostaglandin F2alpha analog [FDA Label]. Having been a well-received therapeutic agent with demonstrated efficacy and safety, travoprost is currently approved by the US FDA as a first-line treatment for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypotension [L5155]. Furthermore, this approval also solidifies the medication as the first and only prostaglandin analog approved by the FDA for first-line treatment of glaucoma patients that does not contain the preservative benzalkonium chloride [L5155]. Moreover, travoprost is also currently approved in the EU for the decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma [L5146, L5152]. |
| Indications and Usage |
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension [F3061, F3064, L5146].
Travoprost is also currently indicated for the decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma [L5146]. |
| Marketing Status |
approved |
| ATC Code |
S01EE04 |
| DrugBank ID |
DB00287
|
| KEGG ID |
D01964
|
| MeSH ID |
D000069557
|
| PubChem ID |
5282226
|
| TTD Drug ID |
D09CZA
|
| NDC Product Code |
82231-114; 54893-0020; 63190-0350; 63629-8840; 61556-040; 64181-0028; 51407-731; 60505-0593; 63629-8839; 24002-0022; 65035-131; 68245-0003; 0781-6185; 40016-006; 0078-0946; 55359-540; 65129-1207 |
| UNII |
WJ68R08KX9
|
| Synonyms |
Travoprost | Travatan Z | Z, Travatan | Travatan | (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester | AL-6221 | AL 6221 | AL6221 |
